Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Vamp5 | Rat | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of VAMP5 mRNA] | CTD | PMID:31150632 | Vamp5 | Rat | 1,2-dimethylhydrazine | increases expression | ISO | Vamp5 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in increased expression of VAMP5 mRNA | CTD | PMID:22206623 | Vamp5 | Rat | 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of VAMP5 mRNA | CTD | PMID:12655037 | Vamp5 | Rat | 17beta-estradiol | decreases expression | ISO | VAMP5 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of VAMP5 mRNA | CTD | PMID:31614463 | Vamp5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of VAMP5 mRNA | CTD | PMID:21215274|PMID:32109520 | Vamp5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Vamp5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of VAMP5 mRNA | CTD | PMID:25975270 | Vamp5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Vamp5 (Mus musculus) | 6480464 | [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression more ... | CTD | PMID:25975270 | Vamp5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Vamp5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of VAMP5 mRNA | CTD | PMID:21570461 | Vamp5 | Rat | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2,3,7,8-tetrachlorodibenzofuran results in decreased expression of VAMP5 mRNA | CTD | PMID:32109520 | Vamp5 | Rat | 2-hydroxypropanoic acid | increases expression | ISO | VAMP5 (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of VAMP5 mRNA | CTD | PMID:30851411 | Vamp5 | Rat | 4,4'-diaminodiphenylmethane | decreases expression | ISO | Vamp5 (Mus musculus) | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of VAMP5 mRNA | CTD | PMID:18648102 | Vamp5 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Vamp5 (Mus musculus) | 6480464 | bisphenol S results in increased expression of VAMP5 mRNA | CTD | PMID:39298647 | Vamp5 | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of VAMP5 mRNA | CTD | PMID:22504374 | Vamp5 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of VAMP5 mRNA | CTD | PMID:24780913 | Vamp5 | Rat | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of VAMP5 mRNA | CTD | PMID:33354967 | Vamp5 | Rat | alpha-Zearalanol | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] affects the expression of VAMP5 mRNA | CTD | PMID:35163327 | Vamp5 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of VAMP5 mRNA | CTD | PMID:16483693 | Vamp5 | Rat | antirheumatic drug | decreases expression | ISO | VAMP5 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of VAMP5 mRNA | CTD | PMID:24449571 | Vamp5 | Rat | aristolochic acid A | increases expression | ISO | VAMP5 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of VAMP5 mRNA | CTD | PMID:33212167 | Vamp5 | Rat | arsane | affects expression | ISO | VAMP5 (Homo sapiens) | 6480464 | Arsenic affects the expression of VAMP5 mRNA | CTD | PMID:18414638 | Vamp5 | Rat | arsenic atom | affects expression | ISO | VAMP5 (Homo sapiens) | 6480464 | Arsenic affects the expression of VAMP5 mRNA | CTD | PMID:18414638 | Vamp5 | Rat | benzo[a]pyrene | increases expression | ISO | VAMP5 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of VAMP5 mRNA | CTD | PMID:20106945|PMID:21632981 | Vamp5 | Rat | benzo[a]pyrene | affects methylation | ISO | VAMP5 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of VAMP5 promoter | CTD | PMID:27901495 | Vamp5 | Rat | benzo[a]pyrene | increases expression | ISO | Vamp5 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of VAMP5 mRNA | CTD | PMID:22228805 | Vamp5 | Rat | benzo[b]fluoranthene | decreases expression | ISO | Vamp5 (Mus musculus) | 6480464 | benzo(b)fluoranthene results in decreased expression of VAMP5 mRNA | CTD | PMID:26377693 | Vamp5 | Rat | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Vamp5 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated more ... | CTD | PMID:39150890 | Vamp5 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of VAMP5 mRNA | CTD | PMID:25181051 | Vamp5 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of VAMP5 mRNA | CTD | PMID:34947998 | Vamp5 | Rat | bisphenol F | multiple interactions | ISO | VAMP5 (Homo sapiens) | 6480464 | [bisphenol F co-treated with Fulvestrant] results in increased methylation of VAMP5 gene | CTD | PMID:31601247 | Vamp5 | Rat | Butylbenzyl phthalate | multiple interactions | ISO | Vamp5 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated more ... | CTD | PMID:39150890 | Vamp5 | Rat | cadmium atom | multiple interactions | ISO | VAMP5 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of VAMP5 more ... | CTD | PMID:31738976 | Vamp5 | Rat | cadmium dichloride | multiple interactions | ISO | VAMP5 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of VAMP5 more ... | CTD | PMID:31738976 | Vamp5 | Rat | calcitriol | increases expression | ISO | VAMP5 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of VAMP5 mRNA | CTD | PMID:21592394 | Vamp5 | Rat | calcitriol | multiple interactions | ISO | VAMP5 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of VAMP5 mRNA | CTD | PMID:21592394 | Vamp5 | Rat | carbon nanotube | decreases expression | ISO | Vamp5 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in decreased expression of VAMP5 mRNA; Nanotubes, Carbon results in decreased more ... | CTD | PMID:25554681 | Vamp5 | Rat | CGP 52608 | multiple interactions | ISO | VAMP5 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to VAMP5 gene] | CTD | PMID:28238834 | Vamp5 | Rat | cisplatin | increases expression | ISO | VAMP5 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of VAMP5 mRNA | CTD | PMID:27392435 | Vamp5 | Rat | clofibrate | multiple interactions | ISO | Vamp5 (Mus musculus) | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of VAMP5 mRNA; PPARA affects the reaction [[Clofibrate more ... | CTD | PMID:17585979 | Vamp5 | Rat | clofibrate | decreases expression | ISO | Vamp5 (Mus musculus) | 6480464 | Clofibrate results in decreased expression of VAMP5 mRNA | CTD | PMID:17585979 | Vamp5 | Rat | crocidolite asbestos | decreases expression | ISO | Vamp5 (Mus musculus) | 6480464 | Asbestos, Crocidolite results in decreased expression of VAMP5 mRNA | CTD | PMID:29279043 | Vamp5 | Rat | Dibutyl phosphate | affects expression | ISO | VAMP5 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of VAMP5 mRNA | CTD | PMID:37042841 | Vamp5 | Rat | dibutyl phthalate | increases expression | ISO | Vamp5 (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of VAMP5 mRNA | CTD | PMID:21266533 | Vamp5 | Rat | dibutyl phthalate | multiple interactions | ISO | Vamp5 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated more ... | CTD | PMID:39150890 | Vamp5 | Rat | diethyl phthalate | multiple interactions | ISO | Vamp5 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated more ... | CTD | PMID:39150890 | Vamp5 | Rat | diisobutyl phthalate | multiple interactions | ISO | Vamp5 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated more ... | CTD | PMID:39150890 | Vamp5 | Rat | diisononyl phthalate | multiple interactions | ISO | Vamp5 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated more ... | CTD | PMID:39150890 | Vamp5 | Rat | diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of VAMP5 mRNA | CTD | PMID:21551480 | Vamp5 | Rat | dorsomorphin | multiple interactions | ISO | VAMP5 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Vamp5 | Rat | doxorubicin | decreases expression | ISO | VAMP5 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of VAMP5 mRNA | CTD | PMID:29803840 | Vamp5 | Rat | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of VAMP5 mRNA | CTD | PMID:29391264 | Vamp5 | Rat | entinostat | increases expression | ISO | VAMP5 (Homo sapiens) | 6480464 | entinostat results in increased expression of VAMP5 mRNA | CTD | PMID:27188386 | Vamp5 | Rat | flavonoids | increases expression | EXP | | 6480464 | Flavonoids results in increased expression of VAMP5 mRNA | CTD | PMID:18035473 | Vamp5 | Rat | fulvestrant | multiple interactions | ISO | VAMP5 (Homo sapiens) | 6480464 | [bisphenol F co-treated with Fulvestrant] results in increased methylation of VAMP5 gene | CTD | PMID:31601247 | Vamp5 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of VAMP5 mRNA | CTD | PMID:33387578 | Vamp5 | Rat | ketoconazole | increases expression | EXP | | 6480464 | Ketoconazole results in increased expression of VAMP5 mRNA | CTD | PMID:37077353 | Vamp5 | Rat | lead diacetate | increases expression | EXP | | 6480464 | lead acetate results in increased expression of VAMP5 mRNA | CTD | PMID:22641619 | Vamp5 | Rat | maneb | multiple interactions | ISO | Vamp5 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of VAMP5 mRNA; Melatonin inhibits the reaction more ... | CTD | PMID:23963992 | Vamp5 | Rat | melatonin | multiple interactions | ISO | Vamp5 (Mus musculus) | 6480464 | Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of VAMP5 mRNA] | CTD | PMID:23963992 | Vamp5 | Rat | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of VAMP5 mRNA | CTD | PMID:22504374 | Vamp5 | Rat | nickel sulfate | increases expression | ISO | VAMP5 (Homo sapiens) | 6480464 | nickel sulfate results in increased expression of VAMP5 mRNA | CTD | PMID:22714537 | Vamp5 | Rat | paracetamol | affects expression | ISO | Vamp5 (Mus musculus) | 6480464 | Acetaminophen affects the expression of VAMP5 mRNA | CTD | PMID:17562736 | Vamp5 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of VAMP5 mRNA | CTD | PMID:33387578 | Vamp5 | Rat | paracetamol | decreases expression | ISO | VAMP5 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of VAMP5 mRNA | CTD | PMID:21420995|PMID:29067470 | Vamp5 | Rat | paracetamol | multiple interactions | ISO | Vamp5 (Mus musculus) | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of VAMP5 mRNA; PPARA affects the reaction [[Clofibrate more ... | CTD | PMID:17585979 | Vamp5 | Rat | paraquat | multiple interactions | ISO | Vamp5 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of VAMP5 mRNA; Melatonin inhibits the reaction more ... | CTD | PMID:23963992 | Vamp5 | Rat | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] affects the expression of VAMP5 mRNA | CTD | PMID:35163327 | Vamp5 | Rat | phenylmercury acetate | increases expression | ISO | VAMP5 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of VAMP5 mRNA | CTD | PMID:26272509 | Vamp5 | Rat | phenylmercury acetate | multiple interactions | ISO | VAMP5 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Vamp5 | Rat | potassium dichromate | increases expression | ISO | Vamp5 (Mus musculus) | 6480464 | Potassium Dichromate results in increased expression of VAMP5 mRNA | CTD | PMID:23608068 | Vamp5 | Rat | rac-lactic acid | increases expression | ISO | VAMP5 (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of VAMP5 mRNA | CTD | PMID:30851411 | Vamp5 | Rat | SB 431542 | multiple interactions | ISO | VAMP5 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Vamp5 | Rat | silicon dioxide | increases expression | ISO | VAMP5 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased expression of VAMP5 mRNA | CTD | PMID:25895662 | Vamp5 | Rat | sodium arsenate | increases expression | ISO | Vamp5 (Mus musculus) | 6480464 | sodium arsenate results in increased expression of VAMP5 mRNA | CTD | PMID:39847705 | Vamp5 | Rat | sodium arsenite | increases expression | ISO | VAMP5 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of VAMP5 mRNA | CTD | PMID:38568856 | Vamp5 | Rat | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of VAMP5 mRNA | CTD | PMID:19281266 | Vamp5 | Rat | sunitinib | decreases expression | ISO | VAMP5 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of VAMP5 mRNA | CTD | PMID:31533062 | Vamp5 | Rat | temozolomide | decreases expression | ISO | VAMP5 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of VAMP5 mRNA | CTD | PMID:31758290 | Vamp5 | Rat | testosterone | multiple interactions | ISO | VAMP5 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of VAMP5 mRNA | CTD | PMID:21592394 | Vamp5 | Rat | testosterone | increases expression | ISO | VAMP5 (Homo sapiens) | 6480464 | Testosterone results in increased expression of VAMP5 mRNA | CTD | PMID:21592394 | Vamp5 | Rat | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of VAMP5 mRNA] | CTD | PMID:31150632 | Vamp5 | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of VAMP5 mRNA | CTD | PMID:31150632 | Vamp5 | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of VAMP5 mRNA | CTD | PMID:34492290 | Vamp5 | Rat | titanium dioxide | decreases methylation | ISO | Vamp5 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of VAMP5 gene; titanium dioxide results in decreased methylation more ... | CTD | PMID:35295148 | Vamp5 | Rat | trichostatin A | increases expression | ISO | VAMP5 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of VAMP5 mRNA | CTD | PMID:24935251 | Vamp5 | Rat | tris(2-butoxyethyl) phosphate | affects expression | ISO | VAMP5 (Homo sapiens) | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of VAMP5 mRNA | CTD | PMID:29024780 | Vamp5 | Rat | urethane | decreases expression | ISO | VAMP5 (Homo sapiens) | 6480464 | Urethane results in decreased expression of VAMP5 mRNA | CTD | PMID:28818685 | Vamp5 | Rat | valproic acid | decreases expression | ISO | VAMP5 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of VAMP5 mRNA | CTD | PMID:29154799 | Vamp5 | Rat | valproic acid | increases expression | ISO | VAMP5 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of VAMP5 mRNA | CTD | PMID:23179753|PMID:24935251|PMID:26272509|PMID:28001369 | Vamp5 | Rat | valproic acid | multiple interactions | ISO | VAMP5 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















